This CSBR PE ratio history page last updated 3/14/2024
Period | Price | Adj. EPS | TTM | PE |
Q3 2024 3/12/2024 | 5.67 | -0.16 | -0.64 | NA | Q2 2024 12/12/2023 | 4.61 | -0.15 | -0.64 | NA | Q1 2024 9/13/2023 | 5.50 | -0.16 | -0.48 | NA | Q4 2023 7/24/2023 | 6.41 | -0.17 | -0.32 | NA | Q3 2023 3/15/2023 | 4.10 | -0.16 | -0.17 | NA | Q2 2023 12/13/2022 | 6.67 | 0.01 | 0.06 | 111.2 | Q1 2023 9/8/2022 | 7.26 | 0.00 | 0.07 | 103.7 | Q4 2022 7/21/2022 | 8.00 | -0.02 | 0.08 | 100.0 | Q3 2022 3/15/2022 | 7.59 | 0.07 | 0.06 | 126.5 | Q2 2022 12/13/2021 | 8.04 | 0.02 | 0.04 | 201.0 | Q1 2022 9/13/2021 | 10.10 | 0.01 | 0.02 | >500 | Q4 2021 7/22/2021 | 10.32 | -0.04 | 0.02 | >500 | Q3 2021 3/11/2021 | 11.00 | 0.05 | -0.08 | NA | Q2 2021 12/14/2020 | 11.55 | 0.00 | -0.10 | NA | Q1 2021 9/14/2020 | 7.58 | 0.01 | -0.08 | NA | Q4 2020 7/27/2020 | 8.95 | -0.14 | -0.14 | NA | Q3 2020 3/12/2020 | 4.19 | 0.03 | -0.01 | NA | Q2 2020 12/16/2019 | 7.61 | 0.02 | -0.04 | NA | Q1 2020 9/16/2019 | 6.90 | -0.05 | -0.03 | NA | Q4 2019 7/15/2019 | 8.99 | -0.01 | 0.07 | 128.4 | Q3 2019 3/18/2019 | 10.61 | 0.00 | 0.04 | 265.2 | Q2 2019 12/17/2018 | 9.55 | 0.03 | 0.04 | 238.8 | Q1 2019 9/13/2018 | 8.48 | 0.05 | 0.01 | >500 | Q4 2018 7/26/2018 | 9.18 | -0.04 | -0.09 | NA | Q3 2018 3/15/2018 | 4.07 | 0.00 | -0.20 | NA | Q2 2018 12/7/2017 | 3.79 | 0.00 | -0.31 | NA | Q1 2018 9/14/2017 | 3.22 | -0.05 | -0.31 | NA | Q4 2017 7/27/2017 | 2.51 | -0.15 | -0.41 | NA | Q3 2017 3/16/2017 | 3.04 | -0.11 | -0.50 | NA | Q2 2017 11/29/2016 | 1.91 | 0.00 | -0.60 | NA | Q1 2017 9/9/2016 | 1.76 | -0.15 | -0.84 | NA | Q4 2016 7/28/2016 | 2.00 | -0.24 | -0.93 | NA | Q3 2016 3/15/2016 | 3.50 | -0.21 | -0.71 | NA | Q2 2016 12/14/2015 | 3.62 | -0.24 | -0.99 | NA | Q1 2016 9/10/2015 | 6.80 | -0.24 | NA | NA | Q4 2015 7/24/2015 | 6.00 | -0.02 | NA | NA | Q3 2015 5/22/2015 | 6.96 | -0.49 | NA | NA |
|
Period | Price | Adj. EPS | Annualized | PE |
Q3 2024 3/12/2024 | 5.67 | -0.16 | -0.64 | NA | Q2 2024 12/12/2023 | 4.61 | -0.15 | -0.60 | NA | Q1 2024 9/13/2023 | 5.50 | -0.16 | -0.64 | NA | Q4 2023 7/24/2023 | 6.41 | -0.17 | -0.68 | NA | Q3 2023 3/15/2023 | 4.10 | -0.16 | -0.64 | NA | Q2 2023 12/13/2022 | 6.67 | 0.01 | 0.04 | 166.8 | Q1 2023 9/8/2022 | 7.26 | 0.00 | 0.00 | NA | Q4 2022 7/21/2022 | 8.00 | -0.02 | -0.08 | NA | Q3 2022 3/15/2022 | 7.59 | 0.07 | 0.28 | 27.1 | Q2 2022 12/13/2021 | 8.04 | 0.02 | 0.08 | 100.5 | Q1 2022 9/13/2021 | 10.10 | 0.01 | 0.04 | 252.5 | Q4 2021 7/22/2021 | 10.32 | -0.04 | -0.16 | NA | Q3 2021 3/11/2021 | 11.00 | 0.05 | 0.20 | 55.0 | Q2 2021 12/14/2020 | 11.55 | 0.00 | 0.00 | NA | Q1 2021 9/14/2020 | 7.58 | 0.01 | 0.04 | 189.5 | Q4 2020 7/27/2020 | 8.95 | -0.14 | -0.56 | NA | Q3 2020 3/12/2020 | 4.19 | 0.03 | 0.12 | 34.9 | Q2 2020 12/16/2019 | 7.61 | 0.02 | 0.08 | 95.1 | Q1 2020 9/16/2019 | 6.90 | -0.05 | -0.20 | NA | Q4 2019 7/15/2019 | 8.99 | -0.01 | -0.04 | NA | Q3 2019 3/18/2019 | 10.61 | 0.00 | 0.00 | NA | Q2 2019 12/17/2018 | 9.55 | 0.03 | 0.12 | 79.6 | Q1 2019 9/13/2018 | 8.48 | 0.05 | 0.20 | 42.4 | Q4 2018 7/26/2018 | 9.18 | -0.04 | -0.16 | NA | Q3 2018 3/15/2018 | 4.07 | 0.00 | 0.00 | NA | Q2 2018 12/7/2017 | 3.79 | 0.00 | 0.00 | NA | Q1 2018 9/14/2017 | 3.22 | -0.05 | -0.20 | NA | Q4 2017 7/27/2017 | 2.51 | -0.15 | -0.60 | NA | Q3 2017 3/16/2017 | 3.04 | -0.11 | -0.44 | NA | Q2 2017 11/29/2016 | 1.91 | 0.00 | 0.00 | NA | Q1 2017 9/9/2016 | 1.76 | -0.15 | -0.60 | NA | Q4 2016 7/28/2016 | 2.00 | -0.24 | -0.96 | NA | Q3 2016 3/15/2016 | 3.50 | -0.21 | -0.84 | NA | Q2 2016 12/14/2015 | 3.62 | -0.24 | -0.96 | NA | Q1 2016 9/10/2015 | 6.80 | -0.24 | -0.96 | NA | Q4 2015 7/24/2015 | 6.00 | -0.02 | -0.08 | NA | Q3 2015 5/22/2015 | 6.96 | -0.49 | -1.96 | NA |
|
On this page we presented the CSBR PE Ratio History information for Champions Oncology' stock.
The average CSBR PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 104.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CSBR PE ratio history based on this TTM earnings result method is 159.4. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this CSBR PE ratio history result, against the recent PE: when this page was posted on 3/13/2024, the most recent closing price for CSBR had been 5.50, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to 0.06. From these numbers, we calculate the recent CSBR PE on 3/13/2024 based on annualized quarterly EPS was 137.5. Based on CSBR's history, that recent PE is elevated relative to the historical average, with the recent PE 31.8% higher than the historical average PE across our data set for Champions Oncology. Looking at the recent CSBR PE on 3/13/2024 based on TTM EPS, we calculate the ratio at 91.7. Based on CSBR's history, that recent PE is low relative to the historical average, with the recent PE 42.5% lower than the average PE across our Champions Oncology data set with TTM EPS used in the calculation at each period.
For self directed investors doing their due diligence on CSBR or any other given stock, valuation analysis for CSBR
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Champions Oncology PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for CSBR. Thanks for visiting, and the next
time you need to research CSBR PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.